“The whole issue of end-to-end testing is a relatively large, time-consuming, and expensive investment for all parties,” stated Dennis Winkler, technical program director of program management at Michigan Blue Cross/Blue Shield of Michigan. “Historically, it usually ends up being used by larger providers, institutions and payers.”

John Wollman, executive vice president of Highpoint Solutions, adds that end-to-end testing also is not “immediately implementable.” In fact, at this point, many providers, clearinghouses, and payers don’t have the systems in place to support end-to-end testing.

Share This Article

Facebook
Twitter
LinkedIn
Email
Print